Cargando…
Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
BACKGROUND: Long-term antithyroid drug therapy has become one of the options for treatment of Graves’ hyperthyroidism. The aim of this study was to compare thyroid status in those who discontinued methimazole (MMI) treatment after 12.8 years with those who continued MMI as long as 24 years. METHODS:...
Autores principales: | Azizi, Fereidoun, Abdi, Hengameh, Amouzegar, Atieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807686/ https://www.ncbi.nlm.nih.gov/pubmed/33446181 http://dx.doi.org/10.1186/s12902-020-00670-w |
Ejemplares similares
-
Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
por: Azizi, Fereidoun, et al.
Publicado: (2021) -
Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter
por: Azizi, Fereidoun, et al.
Publicado: (2022) -
Toward Ultimate Care for Graves’ Hyperthyroidism
por: Azizi, Fereidoun, et al.
Publicado: (2019) -
A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?
por: Abdi, Hengameh, et al.
Publicado: (2020) -
Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review
por: Abdi, Hengameh, et al.
Publicado: (2018)